Short-term Memory Assessment in Patients With Poststroke Aphasia
Aphasia, Acquired, Short-Term Memory Impairment
About this trial
This is an interventional diagnostic trial for Aphasia, Acquired focused on measuring aphasia, short-term memory, assessment
Eligibility Criteria
Inclusion Criteria aphasia patients: Aphasia after an initial ischemic or hemorrhagic stroke diagnosed by the speech pathologist and a screening instrument to evaluate aphasia (ScreeLing) Age 18-85 years Speak Dutch as a mother language Acute to subacute phase poststroke Imaging (CT/MRI) is available prior to inclusion Signed informed consent Exclusion Criteria aphasia patients: There is a history of other diseases of the central nervous system causing non-stroke related speech-, language or cognitive disorder They present severe sensory impairment or other co-morbidities prohibiting administration of the assessment tool Excessive active alcohol or drug abuse Transient ischemic attack (i.e., TIA) Inclusion Criteria healthy participants: Normal score (> 26) on the Montreal Cognitive Assessment (MOCA) Speak Dutch as a mother language Exclusion Criteria aphasia patients: Have no history of stroke or other central nervous system diseases that affect speech, language or cognition Have no severe auditory or visual disorders
Sites / Locations
- Ghent University Hospital
- University Hospital Ghent
Arms of the Study
Arm 1
Arm 2
Other
Other
Short term memory assessment in patients with aphasia.
short term memory assessment in healthy volunteers
Evaluation of short term memory in a patient population with poststroke aphasia using a dutch version of the Temple Assessment of Language and Verbal Short-Term memory in aphasia (TALSA).
Evaluation of short term memory in healthy volunteers using a dutch version of the Temple Assessment of Language and Verbal Short-Term memory in aphasia (TALSA).